Twist Bioscience Corporation (TWST) Cash Flow Statement

The OCF/NI ratio of -0.03 in 2026Q3 indicates that operating cash flow is not yet a reliable indicator of earnings quality, as the company continues to report substantial net losses. The positive OCF appears driven by a $3.3M working capital benefit and $18.2M in stock-based compensation, which are non-cash in nature. Investors should monitor whether this positive OCF is sustainable or a one-off, given the historical pattern of negative OCF in most quarters.

The FCF margin improved to -7.2% in 2026Q3 from -33.5% in 2026Q1, suggesting that revenue growth is beginning to outpace cash outflows, but the company is still consuming cash at a significant rate. The positive OCF in 2026Q3 is a notable inflection, yet the cumulative FCF over the last ten quarters remains deeply negative, indicating that the company has not yet reached a self-sustaining cash flow position. This trajectory suggests that external funding may be needed if the burn rate does not continue to decline.

The sharp increase in capex, from under $1M per quarter in 2024 to nearly $10M in 2026Q3, suggests that Twist is investing heavily in its 'Factory of the Future' to support future growth. This elevated capital intensity may pressure near-term FCF, but it appears aligned with management's strategy to achieve scale and improve gross margins over time. Investors should monitor whether this capex translates into higher utilization and margin expansion, as the current depreciation expense of ~$6-7M per quarter is already a significant fixed cost.

The positive working capital contribution in 2026Q3 helped drive the positive OCF, but the prior quarter's negative swing of -$13.4M highlights the lumpiness in cash flow from operations. This volatility may reflect customer ordering patterns, particularly in the NGS segment, where pilot programs can lead to inventory stocking effects. Investors should watch for sustained improvements in working capital efficiency, as the company scales, to reduce cash flow unpredictability.

The absence of shareholder returns is consistent with a pre-profitability growth company that is prioritizing investment in manufacturing capacity and R&D. The negligible buyback activity suggests that management is not attempting to support the stock price through capital returns, which may be prudent given the cash burn. Investors should monitor the cash runway, as the company's net margin of -20.63% and negative FCF imply a potential need for future equity raises if losses persist.